Health Care M&A Deals, Week Ending September 21, 2018

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in […]

 

Jefferson Health and Einstein Healthcare Agree to Merge

Two Philadelphia-based not-for-profit health systems have agreed to merge. Einstein Healthcare Network and Jefferson Health System signed a definitive agreement on September 14, following their letter of intent signing in March 2018. Einstein is a leading healthcare sytem with approximately 1,000 beds. It includes Einstein Medical Center Philadelphia (548 beds), Einstein Medical Center Montgomery, and […]

 

Evolent Health Acquires New Century

Managed care company Evolent Health (NYSE: EVH) made its first acquisition in two years with the purchase of privately held New Century Health for up to $217 million. New Century, previously owned by NCIS Holdings, Inc., is a specialty care management company focused primarily on cancer and cardiac care. It manages approximately 462,000 Medicare Advantage (MA) […]

 

Reliant Rehabilitation Sold to H.I.G. Capital

Rehabilitation deals aren’t made public very frequently, but when the target is big enough, we hear about them. That was the case when H.I.G. Capital announced the closing of its acquisition of Reliant Rehabilitation Holdings, Inc., a leading provider of therapy services, including physical, occupational and speech, to skilled nursing facilities. Headquartered in Plano, Texas, […]

 

Test tubes filled with money
Test tubes filled with money

Amicus Therapeutics Buys Gene Therapy Company

Amicus Therapeutics (NASDAQ: FOLD) is focused on rare and orphan diseases. So it’s no head-scratcher that the Cranbury, New Jersey-based biotech agreed to shell out $100 million to acquire Celenex. a clinical-stage gene therapy company in Columbus, Ohio. Celenex’ lead programs in CLN6, CLN3 and CLN8 Batten disease are potential first-to-market curative therapies for these […]

This Is (Not) Spinal Tap

We’ve seen a rash of deals for all things spinal in recent weeks, from Stryker Corp.‘s (NYSE: SYK) $1.4 billion deal for K2M Group (NASDAQ: KTWO) to IZI Medical‘s acquisition of Benvenue Medical‘s vertebral augmentation systems. What’s the occasion? Well, it’s that time of year when the big medical conferences loom. The Society for Minimally […]

Health Care M&A Deals, Week Ending September 14, 2018

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in […]

DW Healthcare Partners Exits Rehab and Enters Behavioral Health

DW Healthcare Partners has had a busy summer, buying a healthcare staffing company and a behavioral health platform, then selling its rehabilitation business. In June, the firm announced its investment in Aequor Healthcare Services in Piscataway, New Jersey, the sixth investment made by DW Healthcare Partners Fund IV, LP. Aequor specializes in healthcare and clinical staffing […]

Welltok Strikes Again, Buying WellPass

Welltok, a portfolio company of New Enterprise Associates since 2013, has boosted its consumer health platform, CafeWell, with the acquisition of WellPass. WellPass was formed in 2017 through the merger of Sense Health and Voxiva. The latter worked with many large payers and organizations on mobile and digital health products. Sense Health focuses on Medicaid […]

Allergan Doubles Down on Aesthetics

September 14 was a big day for Allergan plc‘s (NYSE: AGN) medical aesthetics business. The company announced its acquisition of Bonti, Inc., a privately held clinical-stage biotech that develops novel, fast-acting neurotoxin programs for aesthetic and therapeutic applications. Later that same day, Allergan hosted a Medical Aesthetics Day in New York, at which its chief […]